BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 37878160)

  • 1. Quantitative and clinical implications of the EARL2 versus EARL1 [
    Cox MC; Jurcka T; Arens AIJ; van Rijk MC; Kaanders JHAM; van den Bosch S
    EJNMMI Res; 2023 Oct; 13(1):91. PubMed ID: 37878160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative implications of the updated EARL 2019 PET-CT performance standards.
    Kaalep A; Burggraaff CN; Pieplenbosch S; Verwer EE; Sera T; Zijlstra J; Hoekstra OS; Oprea-Lager DE; Boellaard R
    EJNMMI Phys; 2019 Dec; 6(1):28. PubMed ID: 31879795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitivity of
    Cysouw MCF; Kramer GM; Heijtel D; Schuit RC; Morris MJ; van den Eertwegh AJM; Voortman J; Hoekstra OS; Oprea-Lager DE; Boellaard R
    EJNMMI Res; 2019 Jul; 9(1):70. PubMed ID: 31363939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combatting the effect of image reconstruction settings on lymphoma [
    Ferrández MC; Eertink JJ; Golla SSV; Wiegers SE; Zwezerijnen GJC; Pieplenbosch S; Zijlstra JM; Boellaard R
    EJNMMI Res; 2022 Jul; 12(1):44. PubMed ID: 35904645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implications of the Harmonization of [
    Jiménez-Ortega E; Agüera R; Ureba A; Balcerzyk M; Wals-Zurita A; García-Gómez FJ; Leal A
    Tomography; 2022 Apr; 8(2):1097-1112. PubMed ID: 35448724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are lesion features reproducible between
    Constantino CS; Oliveira FPM; Silva M; Oliveira C; Castanheira JC; Silva Â; Vaz SC; Vieira P; Costa DC
    Eur Radiol; 2021 May; 31(5):3071-3079. PubMed ID: 33125562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Convolutional neural networks for automatic image quality control and EARL compliance of PET images.
    Pfaehler E; Euba D; Rinscheid A; Hoekstra OS; Zijlstra J; van Sluis J; Brouwers AH; Lapa C; Boellaard R
    EJNMMI Phys; 2022 Aug; 9(1):53. PubMed ID: 35943622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitivity of an AI method for [
    Ferrández MC; Golla SSV; Eertink JJ; de Vries BM; Wiegers SE; Zwezerijnen GJC; Pieplenbosch S; Schilder L; Heymans MW; Zijlstra JM; Boellaard R
    EJNMMI Res; 2023 Sep; 13(1):88. PubMed ID: 37758869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Confirmation of the prognostic value of pretherapeutic tumor SUR and MTV in patients with esophageal squamous cell carcinoma.
    Hofheinz F; Li Y; Steffen IG; Lin Q; Lili C; Hua W; van den Hoff J; Zschaeck S
    Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1485-1494. PubMed ID: 30949816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental Multicenter and Multivendor Evaluation of the Performance of PET Radiomic Features Using 3-Dimensionally Printed Phantom Inserts.
    Pfaehler E; van Sluis J; Merema BBJ; van Ooijen P; Berendsen RCM; van Velden FHP; Boellaard R
    J Nucl Med; 2020 Mar; 61(3):469-476. PubMed ID: 31420497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor to cervical spinal cord standardized uptake ratio (SUR) improves the reproducibility of
    van den Bosch S; Dijkema T; Philippens MEP; Terhaard CHJ; Hoebers FJP; Kaanders JHAM; Oyen WJG
    Radiother Oncol; 2019 Jan; 130():39-45. PubMed ID: 30005954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EARL compliance measurements on the biograph vision Quadra PET/CT system with a long axial field of view.
    Prenosil GA; Hentschel M; Weitzel T; Sari H; Shi K; Afshar-Oromieh A; Rominger A
    EJNMMI Phys; 2022 Apr; 9(1):26. PubMed ID: 35394263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Tracer Uptake Time in Non-Small Cell Lung Cancer
    Kolinger GD; García DV; Kramer GM; Frings V; Zwezerijnen GJC; Smit EF; de Langen AJ; Buvat I; Boellaard R
    J Nucl Med; 2022 Jun; 63(6):919-924. PubMed ID: 34933890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of time-of-flight technique on the diagnostic performance of 18F-FDG PET/CT for assessment of lymph node metastases in head and neck squamous cell carcinoma.
    Li CY; Klohr S; Sadick H; Weiss C; Hoermann K; Schoenberg SO; Sadick M
    J Nucl Med Technol; 2014 Sep; 42(3):181-7. PubMed ID: 24970897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of ultrasound guided fine needle aspiration cytology results by FDG PET-CT for lymph node metastases in head and neck squamous cell carcinoma patients.
    Peltenburg B; de Keizer B; Dankbaar JW; de Boer M; Willems SM; Philippens MEP; Terhaard CHJ; de Bree R
    Acta Oncol; 2018 Dec; 57(12):1687-1692. PubMed ID: 30489180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative PET-SUVmax and volume based PET parameters of the primary tumor fail to predict nodal upstaging in early-stage lung cancer.
    Okumus Ö; Mardanzai K; Plönes T; Theegarten D; Darwiche K; Schuler M; Nensa F; Hautzel H; Hermann K; Stuschke M; Hegedus B; Aigner C
    Lung Cancer; 2023 Feb; 176():82-88. PubMed ID: 36623341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Why harmonization is needed when using FDG PET/CT as a prognosticator: demonstration with EARL-compliant SUV as an independent prognostic factor in lung cancer.
    Houdu B; Lasnon C; Licaj I; Thomas G; Do P; Guizard AV; Desmonts C; Aide N
    Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):421-428. PubMed ID: 30218317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of Metastatic Mediastinal Lymph Nodes of Non-Small Cell Lung Cancer on Preoperative F-18 FDG PET/CT.
    Lee AY; Choi SJ; Jung KP; Park JS; Lee SM; Bae SK
    Nucl Med Mol Imaging; 2014 Mar; 48(1):41-6. PubMed ID: 24900137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of maximum standardized uptake value measured by pretreatment 18F-FDG PET/CT in locally advanced head and neck squamous cell carcinoma.
    Cacicedo J; Fernandez I; Del Hoyo O; Navarro A; Gomez-Iturriaga A; Pijoan JI; Martinez-Indart L; Escudero J; Gomez-Suarez J; de Zarate RO; Perez JF; Bilbao P; Rades D
    Clin Transl Oncol; 2017 Nov; 19(11):1337-1349. PubMed ID: 28540535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.